Lv5
840 积分 2023-08-13 加入
Exploiting protease activation for therapy
4个月前
已完结
Tumor-selective activity of XTX202, a protein-engineered IL-2, in mice without peripheral toxicities in nonhuman primates
4个月前
已关闭
Antitumour actions of interferons: implications for cancer therapy
6个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
7个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
7个月前
已完结
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance
8个月前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
8个月前
已完结
Fit-for-Purpose Immunohistochemical Biomarkers
9个月前
已完结
Harnessing cytokines and chemokines for cancer therapy
9个月前
已完结
A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice
11个月前
已完结
皖公网安备34019202002308
